| pubmed-article:12686527 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12686527 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:12686527 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:12686527 | lifeskim:mentions | umls-concept:C0027662 | lld:lifeskim |
| pubmed-article:12686527 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:12686527 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12686527 | pubmed:dateCreated | 2003-4-10 | lld:pubmed |
| pubmed-article:12686527 | pubmed:abstractText | Multiple endocrine neoplasia type 2 (MEN 2) is caused by RET proto-oncogene mutations and has a strong penetrance for medullary thyroid carcinoma (MTC). Subtypes are defined by the presence or absence of pheochromocytomas, hyperparathyroidism, and characteristic clinical stigmas. We hypothesize that specific RET mutations correlate with the MEN 2 phenotype and aggressiveness of MTC. | lld:pubmed |
| pubmed-article:12686527 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12686527 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686527 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12686527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686527 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686527 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12686527 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12686527 | pubmed:issn | 0004-0010 | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:EvansDouglas... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:GagelRobert... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:LeeJeffrey... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:SellinRena... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:ShapiroSuzann... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:ShermanSteven... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:CoteGilbert... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:AyersGregory... | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:YipLinwahL | lld:pubmed |
| pubmed-article:12686527 | pubmed:author | pubmed-author:HerzogCynthia... | lld:pubmed |
| pubmed-article:12686527 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12686527 | pubmed:volume | 138 | lld:pubmed |
| pubmed-article:12686527 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12686527 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12686527 | pubmed:pagination | 409-16; discussion 416 | lld:pubmed |
| pubmed-article:12686527 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:meshHeading | pubmed-meshheading:12686527... | lld:pubmed |
| pubmed-article:12686527 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12686527 | pubmed:articleTitle | Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. | lld:pubmed |
| pubmed-article:12686527 | pubmed:affiliation | Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. | lld:pubmed |
| pubmed-article:12686527 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12686527 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12686527 | lld:pubmed |
